TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Biospecialisten Sverige AB
Closing information (x1000 SEK)
| Closing information | 2024/04 | 2023/04 | 2022/04 |
| Turnover |
1,027
|
1,220
|
1,982 |
| Financial expenses |
37
|
16
|
11 |
| Earnings before taxes |
-73
|
-109
|
172 |
| EBITDA |
14
|
-93
|
259 |
| Total assets |
488
|
450
|
386 |
| Current assets |
95
|
121
|
196 |
| Current liabilities |
375
|
265
|
91 |
| Equity capital |
113
|
185
|
284 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Solvency |
23.2%
|
41.1%
|
73.6% |
| Turnover per employee |
1,027
|
1,220
|
1,982 |
| Profit as a percentage of turnover |
-7.1%
|
-8.9%
|
8.7% |
| Return on assets (ROA) |
-7.4%
|
-20.7%
|
47.4% |
| Current ratio |
25.3%
|
45.7%
|
215.4% |
| Return on equity (ROE) |
-64.6%
|
-58.9%
|
60.6% |
| Change turnover |
-193
|
-762
|
298 |
| Change turnover % |
-16%
|
-38%
|
18% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.